A Single-Center, Randomized, Placebo- and Positive-Controlled, Parallel-Group Study of the Electrocardiographic Effects of Dalbavancin in Healthy Male and Female Subjects

Trial Profile

A Single-Center, Randomized, Placebo- and Positive-Controlled, Parallel-Group Study of the Electrocardiographic Effects of Dalbavancin in Healthy Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2012

At a glance

  • Drugs Dalbavancin (Primary) ; Moxifloxacin
  • Indications Bacterial infections; Diabetic foot ulcer; Osteomyelitis; Pneumonia; Skin and soft tissue infections
  • Focus Adverse reactions
  • Most Recent Events

    No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top